샘플 요청 목록

 카트 문의
시장보고서
상품코드
1605708

리보핵산(RNA) 시장 : 종류별, 기술별, 전달 방법별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Ribonucleic Acid Market, By Type, By Technology, By Delivery Method, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 345 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

리보핵산(RNA) 시장 규모는 2023년 3억 4,500만 달러로 평가되며 2024년부터 2032년까지 8.5%의 CAGR로 확대될 것으로 예상됩니다.

리보핵산의 시장 역학

유전자 치료에 대한 관심 증가로 리보핵산 시장 확대 견인

유전자 치료에 대한 관심이 높아지면서, 특히 mRNA 치료제의 발전으로 인해 리보핵산(RNA) 시장 확대에 큰 기여를 하고 있습니다. 예를 들어, 2023년 미국 식품의약국(FDA)은 여러 가지 새로운 RNA 기반 치료제를 승인하여 유전성 질환 및 암 치료 옵션을 강화했으며, RNA 기반 연구에 대한 투자 증가는 시장 성장을 더욱 촉진하고 있으며, 암 치료를 위한 RNA 활용을 목표로 하는 Moderna와 Merck의 제휴와 같은 주목할 만한 공동 연구도 있습니다. 암 치료에 RNA를 활용하기 위한 Moderna와 Merck의 제휴와 같은 주목할 만한 공동연구가 있습니다. 특히 COVID-19 팬데믹 기간 동안 mRNA 백신의 성공은 인식이 더욱 높아져 RNA 기술을 보다 광범위한 의료 응용 분야에 대한 탐색을 가속화하고 있으며, RNA가 유전성 질환을 표적으로 삼아 의료에 혁명을 일으킬 수 있는 잠재력으로 인해 RNA 치료에 초점을 맞춘 연구 자금과 임상시험의 수가 크게 증가했습니다. 모두 크게 증가하고 있습니다. 이러한 변화는 맞춤의료와 정밀치료에 대한 전 세계적인 관심의 증가와 맞물려 RNA를 현대 생명공학의 핵심 초점으로 자리매김하고 있습니다.

리보핵산 시장 : 주요 고려사항

리서치 애널리스트의 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 매년 약 8.5%의 CAGR로 성장할 것으로 예상됩니다.

시장별로는 mRNA(메신저 RNA)가 2023년 가장 큰 시장 점유율을 보일 것으로 예측됐습니다.

기술별로는 RNA 시퀀싱이 2023년 주요 유형으로 꼽혔습니다.

전달 방법별로는 2023년 지질 나노입자가 주요 유형으로 나타났습니다.

지역별로는 북미가 2023년 매출 1위

리보핵산 시장 : 세분화 분석

세계 리보핵산 시장은 유형, 기술, 전달 방법, 최종사용자 및 지역에 따라 세분화됩니다.

mRNA(메신저 RNA), rRNA(리보솜 RNA), tRNA(전사 RNA). mRNA(메신저 RNA)는 백신 개발 및 유전자 치료에 중요한 역할을 하기 때문에 가장 높은 우선순위를 차지하며, rRNA(리보솜 RNA)는 단백질 합성에 필수적이기 때문에 그 뒤를 이어 tRNA(전사 RNA)는 세포 과정에서의 번역을 지원합니다.

RNA 시퀀싱, PCR 기반 RNA 분석, 마이크로어레이 분석의 세 가지 범주로 나뉘며, RNA 시퀀싱은 전사체 및 유전자 발현을 분석할 수 있는 능력으로 인해 주요 기술로 자리 잡았습니다. 유전자 증폭을 위한 신뢰할 수 있는 방법이며, 마이크로어레이 분석은 유전자 발현 프로파일링에 사용됩니다.

리보핵산 시장 : 지역별 분석

북미는 현재 리보핵산(RNA) 시장을 선도하고 있으며, 생명공학 기업의 집적화와 RNA 연구에 대한 대규모 투자가 그 원동력이며, 2023년에는 mRNA 분야의 선도기업인 Moderna가 미국에서 mRNA 기반 백신 생산 시설을 확장하고, RNA 치료제에 대한 이 지역의 우위를 강조하고 있습니다. 미국 정부도 국립보건원(NIH)의 유전자 기반 치료에 대한 투자와 같은 이니셔티브를 통해 RNA 연구에 대한 자금 지원을 늘리고 있습니다. 유럽도 영국, 독일 등 여러 국가들이 RNA 기반 의약품의 임상시험과 의약품 허가에서 큰 진전을 보이고 있습니다. 아시아태평양에서는 중국과 일본이 생명공학 분야의 확대로 인해 중요한 플레이어로 부상하고 있으며, 일본에서는 2024년 최초의 mRNA 기반 암 백신이 승인될 예정입니다. 이들 지역은 RNA 기반 치료를 가속화하고 있을 뿐만 아니라 진단 도구와 RNA 기반 의약품 생산의 가용성을 높여 세계 시장 활동의 활성화에 기여하고 있습니다.

리보핵산 시장 : 경쟁 상황

북미는 리보핵산(RNA) 시장의 경쟁 구도를 주도하고 있으며, 주로 Moderna, Pfizer, CureVac 등 업계 선두주자들이 주도하고 있습니다. 2023년 Moderna는 mRNA 기반 암 백신 연구를 확대할 계획이며, 이는 종양학 분야에서 중요한 움직임이 될 것입니다. 이 되었습니다. 화이자(Pfizer)는 바이오엔텍(BioNTech)과 함께 희귀 유전성 질환 치료를 포함한 RNA 백신 포트폴리오의 발전에 주력하고 있습니다. 유럽에서는 바이오엔텍과 아스트라제네카 등이 RNA 치료제 개발 및 RNA 백신 연구개발에 적극 나서고 있습니다. 주목할 만한 제휴는 바이오엔텍과 로슈의 2024년 감염병용 mRNA 백신 공동개발을 위한 제휴입니다. 한편, 아시아태평양에서는 중국의 시노백(Sinovac)이 RNA 치료제 분야에 진출해 이 지역의 생명공학에 대한 관심이 높아지고 있음을 반영하고 있습니다. 이 지역은 또한 RNA 연구에 대한 전략적 투자와 대학과 생명공학 기업의 공동 연구로 이익을 얻고 있으며, M&A도 계속해서 시장을 형성하고 있으며, RNA를 전문으로하는 여러 소규모 스타트 업이 RNA 기반 제품을 강화하기 위해 대형 제약 회사에 인수되고 있습니다.

목차

제1장 리보핵산 시장 개요

  • 조사 범위
  • 시장 추정 기간

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 리보핵산의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 전망 동향

제4장 리보핵산 시장 : 산업 분석

  • PEST 분석
  • Porter's Five Forces 분석
  • 시장 성장 전망 : 매핑
  • 규제 체제 분석

제5장 리보핵산 시장 : 높아지는 지정학적 긴장의 영향

  • COVID-19 팬데믹의 영향
  • 러시아·우크라이나 전쟁의 영향
  • 중동 분쟁의 영향

제6장 리보핵산 시장 상황

  • 리보핵산 시장 점유율 분석(2023년)
  • 주요 제조업체별 내역 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 리보핵산 시장 : 종류별

  • 개요
    • 부문 점유율 분석 : 종류별
    • mRNA(메신저 RNA)
    • rRNA(리보솜 RNA)
    • tRNA(전이 RNA)
    • 기타

제8장 리보핵산 시장 : 기술별

  • 개요
    • 부문 점유율 분석 : 기술별
    • RNA 시퀀싱
    • PCR 기반 RNA 분석
    • 마이크로어레이 해석

제9장 리보핵산 시장 : 전달 방법별

  • 개요
    • 부문 점유율 분석 : 전달 방법별
    • 지질 나노입자
    • 일렉트로포레이션
    • 바이러스 벡터

제10장 리보핵산 시장 : 최종사용자별

  • 개요
    • 부문 점유율 분석 : 최종사용자별
    • 제약회사
    • 바이오테크놀러지 기업
    • 학술연구기관
    • 병원·진단 검사실

제11장 리보핵산 시장 : 지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제12장 주요 벤더 분석 : 리보핵산 업계

  • 경쟁 대시보드
  • 기업 개요
    • Abcam Plc
    • Agilent Technologies, Inc.
    • Alnylam Pharmaceuticals, Inc.
    • BioNTech SE
    • Bio-Rad Laboratories Inc.
    • GSK plc
    • Illumina, Inc.
    • Ionis Pharmaceuticals, Inc.
    • Lonza Group Ltd.
    • Moderna, Inc.
    • Oxford Nanopore Technologies
    • Qiagen NV
    • Regeneron Pharmaceuticals, Inc.
    • Roche Diagnostics
    • Sarepta Therapeutics, Inc.
    • Thermo Fisher Scientific Inc.
    • Others

제13장 AnalystView 전방위적 분석

ksm 24.12.16

REPORT HIGHLIGHT

Ribonucleic Acid Market size was valued at USD 345 Million in 2023, expanding at a CAGR of 8.5% from 2024 to 2032.

The ribonucleic acid (RNA) market is primarily focused on the study and use of RNA molecules for various research, diagnostic, and therapeutic applications. RNA plays a critical role in cellular processes, and its potential in gene expression regulation and therapeutic delivery is expanding. Increased demand for RNA-based therapies, such as RNA vaccines, is a key factor behind the market's growth, as seen with the success of COVID-19 mRNA vaccines developed by companies like Moderna and Pfizer. Additionally, the growing interest in gene therapies, RNA interference (RNAi) treatments, and advancements in genomic research provide further momentum. However, challenges such as the high cost of RNA-based therapies and concerns about RNA stability and delivery methods hinder widespread adoption. Opportunities for growth exist in emerging markets, especially with increasing investments in biotech startups and expanding research in oncology, rare genetic disorders, and autoimmune diseases, where RNA-based treatments show significant promise. In 2023, investments in RNA technology increased by over 15%, reflecting a strong commitment to innovation.

Ribonucleic Acid Market- Market Dynamics

Growing Interest in Gene Therapies Drives Expansion in the Ribonucleic Acid Market

The growing interest in gene therapies is significantly contributing to the expansion of the ribonucleic acid (RNA) market, particularly with advancements in mRNA therapeutics. In 2023, for example, the U.S. Food and Drug Administration (FDA) approved several new RNA-based treatments, enhancing treatment options for genetic disorders and cancers. A rise in investments in RNA-based research is further bolstering the market's growth, with notable collaborations such as the partnership between Moderna and Merck, which aims to leverage RNA for cancer treatment. The success of mRNA vaccines, especially during the COVID-19 pandemic, has further raised awareness and accelerated the exploration of RNA technologies for broader medical applications. With the potential for RNA to revolutionize healthcare by targeting genetic diseases, there is substantial growth in both research funding and the number of clinical trials focused on RNA therapies. This shift aligns with a growing global interest in personalized medicine and precision treatments, establishing RNA as a core focus in modern biotechnology.

Ribonucleic Acid Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2024-2032)

Based on Type segmentation, mRNA (messenger RNA) was predicted to show maximum market share in the year 2023

Based on Technology segmentation, RNA Sequencing was the leading type in 2023

Based on Delivery Method segmentation, Lipid nanoparticles were the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Ribonucleic Acid Market- Segmentation Analysis:

The Global Ribonucleic Acid Market is segmented on the basis of Type, Technology, Delivery Method, End-User, and Region.

The market is divided into three categories based on Type: mRNA (messenger RNA), rRNA (ribosomal RNA), and tRNA (transfer RNA). mRNA (messenger RNA) holds the highest priority due to its prominent role in vaccine development and gene therapies. rRNA (ribosomal RNA) follows as it is crucial for protein synthesis, while tRNA (transfer RNA) supports translation in cellular processes.

The market is divided into three categories based on Technology: RNA Sequencing, PCR-based RNA Analysis, and Microarray Analysis. RNA sequencing is the leading technology due to its ability to analyze transcriptomes and gene expression. PCR-based RNA analysis follows as a reliable method for gene amplification, while microarray analysis is used for gene expression profiling.

Ribonucleic Acid Market- Geographical Insights

North America is currently leading the ribonucleic acid (RNA) market, driven by the high concentration of biotech firms and substantial investments in RNA research. In 2023, Moderna, a key player in the mRNA space, expanded its mRNA-based vaccine production facilities in the U.S., underscoring the region's dominance in RNA therapeutics. The U.S. government has also increased funding for RNA research, with initiatives like the National Institutes of Health's (NIH) investment in gene-based therapies. Europe follows closely, with countries like the UK and Germany making significant strides in clinical trials and regulatory approvals for RNA-based drugs. In Asia-Pacific, China and Japan are emerging as important players due to their expanding biotech sectors, with Japan's approval of the first mRNA-based cancer vaccine in 2024. These regions are not only accelerating RNA-based therapies but also increasing the availability of diagnostic tools and RNA-based drug production, contributing to a global increase in market activity.

Ribonucleic Acid Market- Competitive Landscape:

North America continues to lead the competitive landscape of the ribonucleic acid (RNA) market, largely driven by industry giants like Moderna, Pfizer, and CureVac. In 2023, Moderna expanded its research into mRNA-based vaccines for cancer, a significant move in the oncology sector. Pfizer, alongside BioNTech, has focused on advancing its RNA vaccine portfolio, including treatments for rare genetic disorders. In Europe, companies such as BioNTech and AstraZeneca are actively developing RNA therapies and collaborating on RNA vaccine research. A notable partnership was the 2024 alliance between BioNTech and Roche to co-develop mRNA vaccines for infectious diseases. Meanwhile, in Asia-Pacific, China's Sinovac is entering the RNA therapeutics space, reflecting the region's growing focus on biotechnology. The region is also benefiting from strategic investments in RNA research and collaborations between universities and biotech firms. Mergers and acquisitions continue to shape the market, with several smaller RNA-focused startups being acquired by larger pharmaceutical companies to enhance their RNA-based offerings.

Recent Developments:

In September 2024, Cytiva launched an advanced RNA delivery LNP kit for its NanoAssemblr Ignite platform. This innovative kit is designed to enhance the formulation and delivery of RNA therapeutics, streamlining the development process for mRNA-based therapies and improving patient outcomes.

In October 2024, Judo Bio launched a Series A funding round to advance its kidney-targeted siRNA therapies. This initiative aims to develop innovative treatments for kidney diseases, leveraging RNA technology to improve patient outcomes and address unmet medical needs in renal health.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RIBONUCLEIC ACID MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abcam Plc
  • Agilent Technologies, Inc.
  • Alnylam Pharmaceuticals, Inc.
  • BioNTech SE
  • Bio-Rad Laboratories Inc.
  • GSK plc
  • Illumina, Inc.
  • Ionis Pharmaceuticals, Inc.
  • Lonza Group Ltd.
  • Moderna, Inc.
  • Oxford Nanopore Technologies
  • Qiagen N.V.
  • Regeneron Pharmaceuticals, Inc.
  • Roche Diagnostics
  • Sarepta Therapeutics, Inc.
  • Thermo Fisher Scientific Inc.
  • Others

GLOBAL RIBONUCLEIC ACID MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • mRNA (messenger RNA)
  • rRNA (ribosomal RNA)
  • tRNA (transfer RNA)
  • Others

GLOBAL RIBONUCLEIC ACID MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • RNA Sequencing
  • PCR-based RNA Analysis
  • Microarray Analysis

GLOBAL RIBONUCLEIC ACID MARKET, BY DELIVERY METHOD- MARKET ANALYSIS, 2019 - 2032

  • Lipid Nanoparticles
  • Electroporation
  • Viral Vectors

GLOBAL RIBONUCLEIC ACID MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic Research Institutes
  • Hospitals & Diagnostic Laboratories

GLOBAL RIBONUCLEIC ACID MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Ribonucleic Acid Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Ribonucleic Acid Market Snippet by Type
    • 2.1.2. Ribonucleic Acid Market Snippet by Technology
    • 2.1.3. Ribonucleic Acid Market Snippet by Delivery Method
    • 2.1.4. Ribonucleic Acid Market Snippet by End-User
    • 2.1.5. Ribonucleic Acid Market Snippet by Country
    • 2.1.6. Ribonucleic Acid Market Snippet by Region
  • 2.2. Competitive Insights

3. Ribonucleic Acid Key Market Trends

  • 3.1. Ribonucleic Acid Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Ribonucleic Acid Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Ribonucleic Acid Market Opportunities
  • 3.4. Ribonucleic Acid Market Future Trends

4. Ribonucleic Acid Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Ribonucleic Acid Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Ribonucleic Acid Market Landscape

  • 6.1. Ribonucleic Acid Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Ribonucleic Acid Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. mRNA (messenger RNA)
    • 7.1.3. rRNA (ribosomal RNA)
    • 7.1.4. tRNA (transfer RNA)
    • 7.1.5. Others

8. Ribonucleic Acid Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 8.1.2. RNA Sequencing
    • 8.1.3. PCR-based RNA Analysis
    • 8.1.4. Microarray Analysis

9. Ribonucleic Acid Market - By Delivery Method

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Delivery Method, 2023 & 2032 (%)
    • 9.1.2. Lipid Nanoparticles
    • 9.1.3. Electroporation
    • 9.1.4. Viral Vectors

10. Ribonucleic Acid Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Pharmaceutical Companies
    • 10.1.3. Biotechnology Companies
    • 10.1.4. Academic Research Institutes
    • 10.1.5. Hospitals & Diagnostic Laboratories

11. Ribonucleic Acid Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Ribonucleic Acid Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Ribonucleic Acid Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Ribonucleic Acid Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Ribonucleic Acid Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Ribonucleic Acid Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Ribonucleic Acid Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Abcam Plc
    • 12.2.2. Agilent Technologies, Inc.
    • 12.2.3. Alnylam Pharmaceuticals, Inc.
    • 12.2.4. BioNTech SE
    • 12.2.5. Bio-Rad Laboratories Inc.
    • 12.2.6. GSK plc
    • 12.2.7. Illumina, Inc.
    • 12.2.8. Ionis Pharmaceuticals, Inc.
    • 12.2.9. Lonza Group Ltd.
    • 12.2.10. Moderna, Inc.
    • 12.2.11. Oxford Nanopore Technologies
    • 12.2.12. Qiagen N.V.
    • 12.2.13. Regeneron Pharmaceuticals, Inc.
    • 12.2.14. Roche Diagnostics
    • 12.2.15. Sarepta Therapeutics, Inc.
    • 12.2.16. Thermo Fisher Scientific Inc.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제